This page has been automatically translated. Please refer to the page in French if needed.
Coronavirus outbreak (COVID-19)
Call for volunteers to test COVID-19 vaccines
Publié le null - Directorate for Legal and Administrative Information (Prime Minister)
From Thursday 1er in october, people who wish to help with research and are ready to test one of the vaccine projects are invited to register on the internet platform . This call for volunteers is launched by the National Institute of Health and Medical Research (Inserm) which needs to recruit 25,000 volunteers.
Who can volunteer?
Any person over 18 years of age who does not have a contraindication to vaccination (for example, those who are seriously ill or taking immunosuppressive therapy).
People who are 65 years of age or older or who have risk factors for COVID-19 (such as diabetes, being overweight, high blood pressure, kidney failure) are particularly encouraged to volunteer. These people may have a weakened immune system, even though they will have to be among the first people vaccinated. The vaccines under study will therefore have to demonstrate their efficacy in these circumstances.
How do I register?
All it takes is pre-register on the national Covireivac platform and complete an initial health questionnaire. If a trial takes place in your area and it suits you, you will be contacted by telephone to offer to participate in a trial that will be explained to you by a doctor. The different trials will take place over about 2 years, so you can be contacted quickly or in several months. It is also possible that you will never be called.
FYI
Volunteers are chosen based on research protocol requirements: age, pre-existing conditions, geographical location.
You can opt out of a trial at any time.
How is the vaccination and follow-up going?
A first date with a doctor to confirm your consent for the trial and a blood test is done for COVID-19 serology.
Vaccination take place in a hospital or nursing home with medical supervision of varying duration depending on the trial and of a maximum of half a day.
You will then be followed between 3 and 12 months. This monitoring consists of regular blood tests or a simple follow-up of symptoms. Monitoring will be closer (up to once a day) during the first week and then weekly during the first month.
Once the test has been completed, you will be followed for 1 to 2 years as part of a monitoring program.
Additional topics
Service-Public.fr
National Institute of Health and Medical Research (Inserm)
Agenda
Apprentissage
Jusqu'au 17 mai 2024
Publié le 03 mai 2024
Impôts
À partir du 11 avr. 2024
Publié le 11 avril 2024
Prévention Covid-19
À partir du 15 avr. 2024
Publié le 18 mars 2024
Calendrier scolaire
Du 6 avr. au 12 mai 2024
Publié le 15 mars 2024